Annual Net Income
-$106.79 M
+$12.41 M+10.41%
December 31, 2023
Summary
- As of February 12, 2025, STRO annual net profit is -$106.79 million, with the most recent change of +$12.41 million (+10.41%) on December 31, 2023.
- During the last 3 years, STRO annual net income has fallen by -$74.67 million (-232.40%).
- STRO annual net income is now -6374.56% below its all-time high of $1.70 million, reached on December 31, 2016.
Performance
STRO Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$48.79 M
-$769.00 K-1.60%
September 30, 2024
Summary
- As of February 12, 2025, STRO quarterly net profit is -$48.79 million, with the most recent change of -$769.00 thousand (-1.60%) on September 30, 2024.
- Over the past year, STRO quarterly net income has dropped by -$79.85 million (-257.05%).
- STRO quarterly net income is now -257.05% below its all-time high of $31.07 million, reached on December 31, 2023.
Performance
STRO Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$123.95 M
+$497.00 K+0.40%
September 30, 2024
Summary
- As of February 12, 2025, STRO TTM net profit is -$123.95 million, with the most recent change of +$497.00 thousand (+0.40%) on September 30, 2024.
- Over the past year, STRO TTM net income has dropped by -$17.16 million (-16.07%).
- STRO TTM net income is now -1081.65% below its all-time high of $12.63 million, reached on September 30, 2020.
Performance
STRO TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
STRO Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.4% | -257.1% | -16.1% |
| 3 y3 years | -232.4% | -257.1% | -16.1% |
| 5 y5 years | -202.4% | -257.1% | -16.1% |
STRO Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1.2% | +10.4% | -257.1% | +16.2% | -17.4% | +28.1% |
| 5 y | 5-year | -232.4% | +10.4% | -257.1% | +18.1% | -1081.7% | +28.1% |
| alltime | all time | -6374.6% | +10.4% | -257.1% | +18.1% | -1081.7% | +28.1% |
Sutro Biopharma Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$48.79 M(+1.6%) | -$123.95 M(-0.4%) |
| Jun 2024 | - | -$48.02 M(-17.5%) | -$124.45 M(+8.3%) |
| Mar 2024 | - | -$58.21 M(-287.4%) | -$114.96 M(+7.6%) |
| Dec 2023 | -$106.79 M(-10.4%) | $31.07 M(-163.0%) | -$106.79 M(-38.1%) |
| Sep 2023 | - | -$49.28 M(+27.9%) | -$172.45 M(+20.9%) |
| Jun 2023 | - | -$38.52 M(-23.0%) | -$142.66 M(+9.6%) |
| Mar 2023 | - | -$50.05 M(+44.7%) | -$130.14 M(+9.2%) |
| Dec 2022 | -$119.20 M(+12.9%) | -$34.59 M(+77.5%) | -$119.20 M(-2.9%) |
| Sep 2022 | - | -$19.49 M(-25.1%) | -$122.73 M(-8.5%) |
| Jun 2022 | - | -$26.01 M(-33.5%) | -$134.15 M(+17.4%) |
| Mar 2022 | - | -$39.11 M(+2.6%) | -$114.29 M(+8.3%) |
| Dec 2021 | -$105.54 M(+228.5%) | -$38.13 M(+23.4%) | -$105.54 M(-16.9%) |
| Sep 2021 | - | -$30.90 M(+402.3%) | -$126.96 M(+60.9%) |
| Jun 2021 | - | -$6.15 M(-79.7%) | -$78.92 M(+84.0%) |
| Mar 2021 | - | -$30.36 M(-49.0%) | -$42.89 M(+33.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$32.13 M(-42.4%) | -$59.54 M(-447.4%) | -$32.13 M(-354.4%) |
| Sep 2020 | - | $17.14 M(-42.6%) | $12.63 M(-172.5%) |
| Jun 2020 | - | $29.87 M(-252.4%) | -$17.42 M(-71.5%) |
| Mar 2020 | - | -$19.59 M(+32.5%) | -$61.09 M(+9.6%) |
| Dec 2019 | -$55.74 M(+57.8%) | -$14.79 M(+14.5%) | -$55.74 M(+31.3%) |
| Sep 2019 | - | -$12.91 M(-6.4%) | -$42.45 M(+6.7%) |
| Jun 2019 | - | -$13.79 M(-3.2%) | -$39.77 M(+6.0%) |
| Mar 2019 | - | -$14.25 M(+854.5%) | -$37.52 M(+6.2%) |
| Dec 2018 | -$35.32 M(+79.4%) | -$1.49 M(-85.4%) | -$35.32 M(-28.2%) |
| Sep 2018 | - | -$10.24 M(-11.3%) | -$49.17 M(+21.9%) |
| Jun 2018 | - | -$11.54 M(-4.2%) | -$40.35 M(+40.1%) |
| Mar 2018 | - | -$12.05 M(-21.5%) | -$28.81 M(+71.9%) |
| Dec 2017 | -$19.69 M(-1256.8%) | -$15.34 M(+982.1%) | -$16.76 M(+1082.1%) |
| Sep 2017 | - | -$1.42 M | -$1.42 M |
| Dec 2016 | $1.70 M | - | - |
FAQ
- What is Sutro Biopharma annual net profit?
- What is the all time high annual net income for Sutro Biopharma?
- What is Sutro Biopharma annual net income year-on-year change?
- What is Sutro Biopharma quarterly net profit?
- What is the all time high quarterly net income for Sutro Biopharma?
- What is Sutro Biopharma quarterly net income year-on-year change?
- What is Sutro Biopharma TTM net profit?
- What is the all time high TTM net income for Sutro Biopharma?
- What is Sutro Biopharma TTM net income year-on-year change?
What is Sutro Biopharma annual net profit?
The current annual net income of STRO is -$106.79 M
What is the all time high annual net income for Sutro Biopharma?
Sutro Biopharma all-time high annual net profit is $1.70 M
What is Sutro Biopharma annual net income year-on-year change?
Over the past year, STRO annual net profit has changed by +$12.41 M (+10.41%)
What is Sutro Biopharma quarterly net profit?
The current quarterly net income of STRO is -$48.79 M
What is the all time high quarterly net income for Sutro Biopharma?
Sutro Biopharma all-time high quarterly net profit is $31.07 M
What is Sutro Biopharma quarterly net income year-on-year change?
Over the past year, STRO quarterly net profit has changed by -$79.85 M (-257.05%)
What is Sutro Biopharma TTM net profit?
The current TTM net income of STRO is -$123.95 M
What is the all time high TTM net income for Sutro Biopharma?
Sutro Biopharma all-time high TTM net profit is $12.63 M
What is Sutro Biopharma TTM net income year-on-year change?
Over the past year, STRO TTM net profit has changed by -$17.16 M (-16.07%)